Tomer Stavitsky Email and Phone Number
Tomer Stavitsky work email
- Valid
- Valid
- Valid
Tomer Stavitsky personal email
- Valid
Tomer Stavitsky phone numbers
Business focused executive with vast strategy and execution experience in companies such as Johnson & Johnson, Pfizer, Intuitive Surgical, ConvaTec, Ginkgo Bioworks, and Allurion Technologies. Specialize in forging strong relationships with senior leaders, entrepreneurs, investors, and key stakeholders to drive innovative business initiatives that fuel exponential growth. Specialized knowledge and large networks in MedTech, AI medical SaaS, Digital Health, and Life Sciences.Proven track record in identifying and capitalizing on transformative M&A such as the $50M acquisition of Orpheus Medical for Intuitive that generated new digital revenue streams in excess of $15M within the second year. I guide key stakeholders towards optimization of strategy and GTM, while nurturing strong strategic partnerships, for example with Medtronic, where I led a new partnership for Allurion, generating $3M within 6 months. Well versed in investments, fundraising, and IPO readiness, including roadshow and prospectus prep, co-leading a $5B IPO for ConvaTec in the UK.Career Highlights• Contributed to Intuitive’s expansion by developing and executing a bottoms up corporate development strategy resulting in a new Israeli R&D center, a $50M acquisition of a digital health company, a pivotal data partnership with a world renown healthcare institution, and new digital related investments and partnerships, together delivering unique competitive advantages and revenue growth.• Led Medtronic pilot to success for Allurion Technologies, meeting all KPIs, building the pilot into a full-fledged partnership and increasing revenue from zero to $3M within 6 months. • Generated investor interest that resulted in an oversubscribed $5B IPO of ConvaTec and led the rebuilding of the company’s strategic planning and corporate development function for a 2x increase in deal flow.• Developed a streamlined corporate development deal process in Pfizer that increased productivity by 25% and led a multi-disciplinary team of 30 for training 100+ professionals on deal phases enabling best-in-class decision support.SKILLSDistinguish The Forest from The Trees Towards The “Big Picture” To Drive Business Results | Connecting Businesses and Individuals in Synergistic Ways | Creative Problem Solving, End to End Ownership and Cross Function Leadership | Helping Companies/Entrepreneurs Understand and Enhance Their Multi-Faceted Value | Optimizing Strategy and Go To Market | Board Level Executive Communication | Understanding The Deeper Organizational “Why” and Challenging The “Status Quo” |
Omnicell
View- Website:
- omnicell.com
- Employees:
- 3419
-
Svp, Chief Corporate Development OfficerOmnicellCalifornia, United States
-
Strategic Partnerships ExecutiveCeevra, Inc. May 2024 - PresentSan Francisco, California, UsIdentify, structure and manage strategic business development partnerships for leading provider of AI-driven 3D imaging for robotic surgeons. -
Head Of Business Development - UsSweetch Jun 2024 - PresentTel Aviv, IlLead US Business Development for innovative digital health company with focus on chronic disease management in Obesity and Diabetes -
Executive Corporate Development / Business Development AdvisorTomer Stavitsky Consulting & Advisory Jan 2023 - PresentSan Jose, California, UsVP Corporate Development helping MedTech, Digital Health, and Life Science Companies, as well as healthcare focused investors with corporate and business development initiatives. Examples include:• Implementing a thesis with a global investment firm to source, diligence, and execute innovative healthcare focused investments and acquisitions.• Advising (via GLG) several investment firms on digital health, surgical robotics, and the Medtech market. Topics include business models, data/AI, commercial scaling strategies etc. • Advised a large and diversified MedTech company with a refresh of their commercial go to market and corporate development efforts around a combination HW/SW AI based surgical navigation product. -
Business MentorAlchemist Accelerator Apr 2024 - PresentUsHelping founders of this fantastic startup accelerator. Focused on MedTech, Digital Health and Lifesciences. Advising around Strategy, GTM, Business Models, Partnerships and Business Development, Pitches etc. -
Executive MemberFractionals United May 2024 - PresentMember and active contributor of this wonderful fractional executives community -
Executive MemberInternational Leap Network Mar 2024 - PresentLos Altos, UsLEAP is a private exclusive network for members of the #LeapAcademy Program: executive leaders, entrepreneurs, and high achievers from around the world who inspire and drive growth and impact on themselves, their work and their communities. -
Investor (Medtech, Life Sciences, Digital Health)Independent Investor Jan 2023 - PresentInvest in Medtech, Life Sciences and Digital Health initiatives / startups -
Vp, Head Of Corporate DevelopmentAllurion Technologies Jul 2023 - Mar 2024Natick, Ma, Us• Led Medtronic collaboration to success towards meeting key KPIs. Generated $3M in 6 months and invested significant efforts into steering into a full-fledged collaboration, with expected revenues in excess of $10M in the second year if executed.• Created multi-pronged, region-specific partnership strategy, to extend Allurion’s reach in key strategic markets. As a first step, partnered with an innovative digital first MedTech company in India, followed by a multi-million $ partnership in the making with a large Indian based Medtech company, advanced discussions with a Chinese conglomerate about mainland China, and other efforts in select markets in Middle East and LATAM. • Sealed gaps with Allurion’s AI enabled weight loss management solution by implementing a digital scale up strategy, and leading efforts to source a digital health startup's CEO to lead Digital Commercialization and Product at Allurion. This resulted in obtaining several large accounts, and growing from zero to $1M projected digital sales in 2024. -
Vp Corporate Development, Head Of M&AGinkgo Bioworks, Inc. May 2022 - Dec 2022Boston, Ma, UsWas responsible for leading M&A and investment activities for Ginkgo Bioworks, a tech enabled high growth, fast moving public company (Ticker: DNA) in the Synthetic Biology space.During my tenure with Ginkgo, I worked on revamping Ginkgo's M&A strategy and on deals that span data analytics, biopharma development, automation, material development and synthetic biology HW/SW solutions. * Led the Altar, Circularis, and Baktus M&A deals, and contributed to the Bitome asset deal. These deals were in aggregate of $100M.* Co-led the transformational Zymergen M&A deal and made contributions to the Bayer/Joyn JV acquisition (combined, in aggregate of over $500M)* Executed on the integration of the recently acquired FGen AG. Rebuilt and refocused the integration plan, streamlining execution and reaching steady state with minimal resources. -
Corporate Development, Partnerships And M&A Lead, Digital & Data Business UnitIntuitive Surgical Jan 2018 - Apr 2022California, 94086, UsLed Intuitive's corporate development activities for the Digital & Data business unit, representing a digital platform with over 30 products and services across B2B and B2C, impacting over 1.2M procedures a year and with over 6,000 da Vinci systems in use worldwide.Evaluated over 100 investment, M&A and technology partnership opportunities that led to unique competitive advantages, revenue growth and cost savings. These included AI/ML, Digital Health, advanced imaging, Telehealth, Data Analytics, Edge Compute, Robotics, XR, Cyber Security, Surgical Instruments and Training Technologies.Contributed to company’s expansion and revenue growth by developing a corporate development strategy for ISRG’s digital and data efforts and led teams to landscape the space and identify transformative opportunities. This resulted in a new Israeli office, the $50M acquisition of Orpheus Medical, and new digital related investments and partnerships, together delivering unique competitive advantages and revenue growth. Led a $15M transformative M&A in the surgical training space with Intuitive gaining advanced surgeon training models and innovative capabilities. Executed the 90-day streamlined integration plan enabling immediate productivity and cost reduction benefits.Co-led the $50M acquisition of technology assets (Internet of Medical Things) from InTouch Health and developed and executed a successful integration plan that created immediate telepresence market opportunities for ISRG and enabled a 4x increase in telepresence session volumes. -
Director, Corporate DevelopmentConvatec Jun 2016 - Jan 2018London, England, GbConvaTec is a Wound Management focused Medical Device Technology company.Originally a Bristol-Myers Squibb spin-off, ConvaTec had a successful IPO in the London Stock Exchange (ticker CTEC.L) and became a member of the FTSE 100.In my role I led company-wide transformative corporate development and corporate finance projects and had the pleasure to play a key role in IPO efforts shortly after joining, resulting in an oversubscribed London Stock Exchange IPO at $5B market cap. Following the IPO, I led the effort to rebuild the strategic planning function and developed and implemented new decision-making tools enabling senior management with best-in-class decision support and standardized, relevant long-range financial analytics. I also led the creation of a new, streamlined, corporate development deal process, resulting in a 2x increase in deal flow. -
Manager, Corporate DevelopmentPfizer Dec 2013 - Apr 2016New York, New York, UsLed and supported the initiation, valuation, progression, negotiation, due-diligence and execution of M&A, licensing, partnership, divestiture and other related business development transactions in pharmaceuticals and biotech. Executed 10 M&A and collaboration deals in aggregate of $6B+ and evaluated over 30 in aggregate of $200B. This resulted in added revenue of more than $1B across Neurology, Hematology, Biosimilars and Generics.Select executed deals: ~$100M collaboration with Medgenesis for innovative Parkinson’s Gene Therapies. $400M acquisition of Innopharma, ~$600M strategic alliance with OpKo for Growth Hormone therapies. These deals strengthened Pfizer’s competitive position and solidified its standing as an innovative pharma company. -
Senior Associate, Strategy & Business DevelopmentJohnson & Johnson Jul 2012 - Dec 2013New Brunswick, Nj, UsParticipated in J&J's MBA Finance Leadership Development Program. Working in the Ethicon subsidiary, I provided strategic and financial Business Development leadership to a $1B global surgical medical device and medical technology business. Spearheaded strategic and financial analysis of a $200M licensing deal and negotiated expanded product exclusivity to Asia markets, generating additional annual revenue potential of $20M. Led strategic planning of pipeline and designed and executed an international portfolio optimization project resulting in $10M cost savings by refocusing and restructuring project spend. -
Mba CandidateUnc Kenan-Flagler Business School 2010 - 2012Chapel Hill, North Carolina, UsKey activities:Teaching Assistant for MBA level Financial Statement Analysis Course - for 9 months, provided coaching and advice to 100+ students participating in the Financial Statement Analysis MBA course.President, Alumni Advisory Board -
New Business Development Mba Intern (Summer Internship) - Ultra Mobility GroupIntel Corporation Jun 2011 - Aug 2011Santa Clara, California, UsCompleted a 3 month MBA summer internship with Intel's Ultra Mobility Group. Devised optimal strategy for Intel’s first smartphone. Analyzed smartphone technology value-chain and identified major strategic differentiation opportunities in silicon and software components. -
Manager, Investment BankingBdo International 2007 - 2010Tel Aviv, IlSupervised 3 associates in global transactions worth up to $500M focusing on Biotech, Medical Device and Medical Technology performing mergers & acquisitions and divestitures advisory and capital/debt raising activities. Led a team to evaluate strategic M&A targets and conducted extensive financial modeling for a leading biotech giant resulting in 5 successful acquisitions totaling over $100M. Secured $10M in financing for a struggling medical device start-up by creating optimal capital structure and applying a creative negotiation and sourcing strategy. -
M&A Associate, Corporate FinanceMbt Advisory 2006 - 2007Tel Aviv, IlProvided M&A advisory services to Technology and Industrial firms.Increased profits of Tnuva’s (Israel’s largest dairy producer) previous shareholders by $25M by uncovering hidden value in Real Estate holdings in a $1B M&A deal with Apax Partners. -
Industrial Engineering Project LeaderIsrael Defense Forces 1999 - 2002Tel Aviv, IlManaged team of 3 soldiers in cost optimization and logistics projects.Generated $3M in cost savings by promoting budget cuts across 20 IDF bases.
Tomer Stavitsky Skills
Tomer Stavitsky Education Details
-
Unc Kenan-Flagler Business SchoolCorporate Finance & Entrepreneurship -
The College Of Management Academic StudiesFinance Major
-
The Open University Of IsraelIndustrial Engineering
Frequently Asked Questions about Tomer Stavitsky
What company does Tomer Stavitsky work for?
Tomer Stavitsky works for Omnicell
What is Tomer Stavitsky's role at the current company?
Tomer Stavitsky's current role is SVP, Chief Corporate Development Officer.
What is Tomer Stavitsky's email address?
Tomer Stavitsky's email address is to****@****ail.com
What is Tomer Stavitsky's direct phone number?
Tomer Stavitsky's direct phone number is +191992*****
What schools did Tomer Stavitsky attend?
Tomer Stavitsky attended Unc Kenan-Flagler Business School, The College Of Management Academic Studies, The Open University Of Israel.
What are some of Tomer Stavitsky's interests?
Tomer Stavitsky has interest in Professional Networking, Technology And Gadgets, Languages, Hikes And International Travel, Strategy And Business Development, Investing, Valuation, Education, Basketball, Personal.
What skills is Tomer Stavitsky known for?
Tomer Stavitsky has skills like Financial Modeling, Financial Analysis, Valuation, Corporate Finance, Mergers And Acquisitions, Due Diligence, Private Equity, Strategy, Dcf Valuation, Business Development, Investment Banking, Business Strategy.
Who are Tomer Stavitsky's colleagues?
Tomer Stavitsky's colleagues are Venkatasai Vangala, Bob Schmid, Arthur Wynn, Konstantin Shev, Csp-Po®, Cpht, Jennifer Mcelravy, Will Winkley, Nicolas Smith.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial